Drug Type Small molecule drug |
Synonyms ID 110410395, ID110410395 |
Target |
Action stimulants, inhibitors |
Mechanism CFTR stimulants(Cystic fibrosis transmembrane conductance regulator stimulants), PDE4 inhibitors(Phosphodieterase 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dry Eye Syndromes | Preclinical | South Korea | 01 May 2025 | |
Xerophthalmia | Preclinical | South Korea | 21 Sep 2023 |